| Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results R Coleman, R De Boer, H Eidtmann, A Llombart, N Davidson, P Neven, ... Annals of oncology 24 (2), 398-405, 2013 | 373 | 2013 |
| Randomized phase II study evaluating palbociclib in addition to letrozole as neoadjuvant therapy in estrogen receptor-positive early breast cancer: PALLET trial. S Johnston, S Puhalla, D Wheatley, A Ring, P Barry, C Holcombe, ... AMER SOC CLINICAL ONCOLOGY, 2019 | 178 | 2019 |
| Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy A Modi, ES Siris, J Tang, S Sen Current medical research and opinion 31 (4), 757-765, 2015 | 57 | 2015 |
| Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA A Wilk, S Sajjan, A Modi, CPS Fan, P Mavros Osteoporosis International 25, 2777-2786, 2014 | 57 | 2014 |
| Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years A Modi, S Sajjan, R Insinga, J Weaver, EM Lewiecki, ST Harris Osteoporosis International 28, 1355-1363, 2017 | 41 | 2017 |
| Reasons for not initiating osteoporosis therapy among a managed care population J Yu, SK Brenneman, V Sazonov, A Modi Patient preference and adherence, 821-830, 2015 | 41 | 2015 |
| Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes A Modi, M Weiner, BA Craig, LP Sands, MB Rosenman, J Thomas III Journal of the American Geriatrics Society 57 (7), 1238-1244, 2009 | 39 | 2009 |
| S1-3: Long-Term Survival Outcomes among Postmenopausal Women with Hormone Receptor-Positive Early Breast Cancer Receiving Adjuvant Letrozole and Zoledronic Acid: 5-Year Follow … R De Boer, N Bundred, H Eidtmann, P Neven, G von Minckwitz, N Martin, ... Cancer Research 71 (24_Supplement), S1-3-S1-3, 2011 | 37 | 2011 |
| Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis ES Siris, A Modi, J Tang, S Gandhi, S Sen Current medical research and opinion 30 (1), 123-130, 2014 | 35 | 2014 |
| Challenges in implementing and maintaining osteoporosis therapy A Modi, S Sajjan, S Gandhi International Journal of Women's Health, 759-769, 2014 | 30 | 2014 |
| Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteoporosis: baseline results … A Modi, S Sen, JD Adachi, S Adami, B Cortet, AL Cooper, P Geusens, ... Osteoporosis International 27, 1227-1238, 2016 | 25 | 2016 |
| The effect of zoledronic acid on aromatase inhibitor associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: the ZO-FAST study 5 … R DeBoer, N Bundred, H Eidtmann, A Llombert, P Neven, ... CANCER RESEARCH 70, 2010 | 25 | 2010 |
| Incremental dementia-related expenditures in a medicaid population MF Bharmal, S Dedhiya, BA Craig, M Weiner, M Rosenman, LP Sands, ... The American Journal of Geriatric Psychiatry 20 (1), 73-83, 2012 | 24 | 2012 |
| Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study T Fan, G Nocea, A Modi, L Stokes, SS Sen Clinical interventions in aging, 689-696, 2013 | 23 | 2013 |
| Cost and consequences of nonadherence with oral bisphosphonate therapy: findings from a real-world data analysis S Sharman Moser, J Yu, I Goldshtein, S Ish-Shalom, V Rouach, V Shalev, ... Annals of Pharmacotherapy 50 (4), 262-269, 2016 | 20 | 2016 |
| History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis J Yu, J Tang, Z Li, S Sajjan, C O’Regan, A Modi, V Sazonov International journal of women's health, 913-918, 2015 | 19 | 2015 |
| Association between gastrointestinal events and compliance with osteoporosis therapy ES Siris, CPS Fan, X Yang, S Sajjan, SS Sen, A Modi Bone Reports 4, 5-10, 2016 | 17 | 2016 |
| Gastrointestinal events among patients initiating osteoporosis therapy: a retrospective administrative claims database analysis A Modi, ES Siris, CPS Fan, S Sajjan Clinical Therapeutics 37 (6), 1228-1234, 2015 | 17 | 2015 |
| Proportion of osteoporotic women remaining at risk for fracture despite adherence to oral bisphosphonates EA Imel, G Eckert, A Modi, Z Li, J Martin, A de Papp, K Allen, CC Johnston, ... Bone 83, 267-275, 2016 | 16 | 2016 |
| Prevalence of renal impairment among osteoporotic women in the USA, NHANES 2005–2008: Is treatment with bisphosphonates an option? R Lubwama, A Nguyen, A Modi, C Diana, PD Miller Osteoporosis International 25, 1607-1615, 2014 | 16 | 2014 |
